Rapid sarcomatous degeneration of an uterine pleomorphic symplastic leiomyoma

Authors

  • Oscar Alejandro Bonilla-Sepúlveda
  • Jaime Díaz-Cardona
  • Álvaro Restrepo-Pareja

DOI:

https://doi.org/10.18597/rcog.410

Keywords:

leiomyoma, leiomyosarcoma, menorrhagia, sepsis

Abstract

Objective: reviewing the epidemiology and clinical-histopathological picture of uterine sarcomas.

Presentation of the case: a 35 year-old woman was attended at the Medellín General hospital (3rd level attention public hospital serving as obstetric referente centre) for genital bleeding. She presented anaemia and a pelvic mass which was revealed to be a high-grade uterine leiomyosarcoma in histopathological study.

Discussion: an atypical benign tumorous lesion was described, having variable cellularity; this degenerated into an aggressive leiomyosarcoma lesion having early-stage symptom attacks.

Author Biographies

Oscar Alejandro Bonilla-Sepúlveda

Médico Cirujano Universidad del Quindío, Residente 3er. año Gineco-Obstetricia Universidad CES, Diplomado Docencia Universitaria Universidad CES. Medellín, Colombia.

Jaime Díaz-Cardona

Médico Cirujano Universidad de Caldas, Especialista Gineco-Obstetricia Universidad de Caldas, Ginecólogo Oncólogo Universidad Javeriana, Instituto Nacional de Cancerología, Especialista Auditoría Médica. Medellín, Colombia.

Álvaro Restrepo-Pareja

Médico Cirujano Universidad Pontificia Bolivariana, Especialista Anatomía Patológica Universidad de Antioquia. Medellín, Colombia.

References

Persaud V. Arjoon PD. Uterine leiomyoma. Incidence of degenerative change and a correlation of associated symptoms. Obstet Gynecol 1970;35:432-6.

Razafintsalama T, Leveque J, Le Gall F, Paumier V, Pangui E, Kerisit J et al. Léiomyosarcome utérin. À propos de 9 observations et revue de la littérature. J Gynecol Obstet Biol Reprod 1997;26:256-62.

Benangiano G, Kivinen ST, Fadini R, Cronjé H, Klintorp S, van der Spuy ZM. Zoladex (goserelin acetate) and anemic patient: results of a multicentre fibroid study. Fertil Steril 1996;66:223-8.

Rein MS, Barbieri RL, Friedman AJ. Progesterone: A critical role in pathogenesis of uterine myomas. Am J Obstet Gynecol 1995;172:14-8.

Smith SK. The regulation of fibroid growth: time for a rethink? Br J Obstet Gynaecol 1993;100:977-9.

Oláh KS, Dunn JA, Gee H. Leiomyosarcomas have a poorer prognosis than mixed mesodermal tumours when adjusting for known prognostic factors: the result of a retrospective study of 423 cases of uterine sarcoma. Br J Obstet Gynaecol 1992;99:590-4.

Nordal RR, Thoresen SO. Uterine sarcomas in Norway 1956-1962: incidence, survival and mortality. Eur J Cancer 1997;33:907-11.

Harlow BL, Weiss NS, Lofton S. The epidemiology of sarcomas of the uterus. J Natl Cancer Inst 1986;76:399-402.

Hoskins WJ, Pérez CA, Young RC. Principles and practice of gynecologic oncology. 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2001.

Brooks SE, Zhan M, Cote T, Baquet CR. Surveillance, epidemiology, and end results analysis of 2677 cases of uterine sarcoma 1989-1999. Gynecol Oncol 2004;93:204-8.

Leibsohn S, d'Ablaing G, Mishell DR Jr, Schlaerth JB. Leiomyosarcoma in a series of hysterectomies performed for presumed uterine leiomyosarcoma. Am J Obstet Gynecol 1990;162:968-76.

Umesaki N, Tanaka T, Miyama M, Kawamura N, Ogita S, Kawade J, et al. Positron emission tomography with (18) fluorodeoxyglucose of uterine sarcoma: a comparison with magnetic resonance imaging and power Doppler imaging. Gynecol Oncol 2001;80:372-7.

Fuller A Jr, Patterson D, Shimm D. Sarcomas of the female genital tract. En: Raaf J, ed. Soft tissue sarcomas: diagnosis and treatment. St. Louis, MO: Mosby; 1993. p. 187-200.

SchwartzLB, Diamond MP, Schwartz PE. Leiomyosarcomas: clinical presentation. Am J Obstet Gynecol 1993;168:180-3.

Forney JP, Buschbaum HJ.Classifying, staging, and treating uterine sarcomas. Contemp Ob Gyn 1981;18:47-69.

Poulsen HE, Taylor CW, Sobin LH, eds. Histological Typing of female genital tract tumours. Geneve: World Health Organization; 1975. p. 13.

Major FJ, Blessing JA, Silverberg SG, Morrow CP, Creasman WT, Currie JL, et al. Prognostic factors in early-stage uterine sarcoma: a Gynecologic Oncology Group study. Cancer 1993;71:1702-9.

Oda K, Okada S, Nei T, Shirai T, Takahashi M, Sano Y, et al. Cytodiagnostic problems in uterine sarcoma. Analysis according to a novel classification of tumor growth types. Acta Cytol 2004;48:181-6.

Omura GA, Major FJ, Blessing JA, Sedlacek TV, Thigpen JT, Creasman WT, et al. A randomized study of adriamycin with and without dimethyl triazenoimidazole carboxamide in advanced uterine sarcomas. Cancer 1983;52:626-32.

Evans HL, Chawla SP, Simpson C, Flinn KP. Smooth muscle neoplasms of the uterus other than ordinary leiomyoma. A study of 46 cases, with emphasis on diagnostic criteria and prognostic factors. Cancer 1988;62:2239-47.

Christopherson WM, Williamson EO, Gray LA. Leiomyosarcoma of the uterus. Cancer 1972;29:1512-7.

How to Cite

1.
Bonilla-Sepúlveda OA, Díaz-Cardona J, Restrepo-Pareja Álvaro. Rapid sarcomatous degeneration of an uterine pleomorphic symplastic leiomyoma. Rev. colomb. obstet. ginecol. [Internet]. 2008 Sep. 30 [cited 2024 Jul. 3];59(3):243-7. Available from: https://revista.fecolsog.org/index.php/rcog/article/view/410

Downloads

Download data is not yet available.

Published

2008-09-30
QR Code

Altmetric

Article metrics
Abstract views
Galley vies
PDF Views
HTML views
Other views
Crossref Cited-by logo

Some similar items: